MOTS-c 10mg Pen

Understanding MOTS-c 10mg:

This product is available as a single use or reusable pen system, which uses refill cartridges for precise and convenient delivery.

Product Strength: 10mg per 2ml cartridge

Storage: Keep at room temperature between 20–25 °C to maintain potency and stability.

What It Is

MOTS-c is a synthetic 16-amino acid peptide and a mitochondrial-derived peptide (MDP). It is encoded within the mitochondrial genome (specifically the 12S rRNA region), distinguishing it from nuclear-encoded peptides. As a member of the mitochondrial-derived peptide family, which includes Humanin and SHLP1-6, MOTS-c functions as a retrograde signaling molecule that communicates mitochondrial status to the nucleus to regulate cellular metabolism and stress responses.

The discovery of MOTS-c in 2015 by researchers at the University of Southern California represented a paradigm shift in understanding mitochondrial function. Prior to this, mitochondria were primarily viewed as cellular powerhouses; the identification of MOTS-c revealed that mitochondria actively secrete regulatory peptides that influence systemic metabolism. This discovery positioned MOTS-c as a potential therapeutic target for metabolic disorders, aging, and age-related diseases.

Mechanism of Action

MOTS-c functions as a hormone-like peptide that regulates metabolic homeostasis through activation of the AICAR (5-aminoimidazole-4-carboxamide ribonucleotide) pathway. Unlike direct AMPK activators, MOTS-c binds to an as-yet-unidentified intracellular receptor, leading to AICAR accumulation, which subsequently activates AMP-activated protein kinase (AMPK) — the cell's master energy sensor.

By activating AMPK, MOTS-c triggers a cascade of metabolic effects:

• Increased glucose uptake in skeletal muscle through GLUT4 translocation

• Enhanced fatty acid oxidation, promoting the utilization of lipids for energy

• Improved mitochondrial biogenesis and efficiency

• Modulation of insulin sensitivity, improving glycemic control

In addition to its metabolic actions, MOTS-c has been shown to influence the cellular stress response by upregulating antioxidant defense mechanisms, reducing oxidative damage, and promoting cellular resilience. This dual action — improving metabolic function while simultaneously enhancing cellular protection — distinguishes MOTS-c from many other metabolic modulators.

Key Research Applications & Uses

Primary Research Applications:

• Metabolic disorders and insulin resistance: MOTS-c is being investigated for its ability to improve insulin sensitivity and glucose homeostasis in models of obesity, type 2 diabetes, and metabolic syndrome. Studies have demonstrated that MOTS-c administration significantly improves glucose tolerance and reduces fasting blood glucose levels in aged and diet-induced obese mice

• Aging and age-related decline: As circulating MOTS-c levels naturally decline with age, research is exploring exogenous administration as a potential intervention to counteract age-associated metabolic dysfunction, muscle weakness, and mitochondrial deterioration

Emerging & Investigational Uses:

• Exercise performance and recovery: MOTS-c is being studied for its ability to mimic the metabolic benefits of exercise, enhancing endurance and facilitating recovery through improved fatty acid oxidation and reduced oxidative stress during physical exertion

• Neuroprotection: Preliminary research suggests MOTS-c may have neuroprotective properties, potentially offering benefits in neurodegenerative conditions through its effects on mitochondrial function and cellular stress resistance

• Bone health: Emerging evidence indicates MOTS-c may play a role in osteoblast differentiation and bone formation, suggesting potential applications in osteoporosis and bone-related disorders

• Weight management: The peptide's ability to enhance energy expenditure and fatty acid oxidation has led to exploration of its potential role in supporting healthy weight management

Administration & Dosage

MOTS-c is typically administered via subcutaneous injection, allowing for systemic distribution and consistent bioavailability.

Timing: For metabolic benefits, dosing may be performed in the morning or before periods of anticipated metabolic demand. For exercise-related applications, administration approximately 30–60 minutes before physical activity is common

Frequency: Dosing protocols vary widely based on research objectives, typically ranging from once daily to several times weekly. Common research dosages range from 5mg to 10mg per administration, with cycle durations of 4–8 weeks commonly reported

Onset & Duration:

• Onset: Effects on metabolism and energy utilization typically begin within 30–60 minutes

• Duration: Acute metabolic effects may persist for 4–6 hours, with cumulative benefits observed with repeated dosing over time

Contraindications & Precautions

MOTS-c is contraindicated or should be used with extreme caution in individuals with the following conditions:

Uncontrolled metabolic disorders: Individuals with uncontrolled diabetes or severe hypoglycemic episodes should exercise caution, as MOTS-c may significantly alter glucose metabolism and insulin sensitivity

Pregnancy and lactation: Safety during pregnancy and breastfeeding has not been established. Use is not recommended in these populations

Hypersensitivity: Known allergy to MOTS-c or any component of the formulation

Cancer or active malignancy: Due to its effects on cellular metabolism and proliferation, use in individuals with active cancer or a history of malignancy should be approached with caution and only under strict medical supervision

Autoimmune conditions: As a bioactive peptide that influences immune and stress signaling pathways, use in autoimmune disorders should be carefully evaluated

Adverse Reactions & Side Effects

The most common side effects associated with MOTS-c are generally mild and include:

Injection site reactions: Local redness, mild pain, or irritation at the injection site — the most frequently reported adverse effect

Flushing: A feeling of warmth or redness of the skin, occasionally reported

Dizziness or lightheadedness: May occur, particularly in individuals sensitive to changes in glucose metabolism

Fatigue: Some users report transient tiredness, particularly during the initial days of use

Mild nausea: Less common, typically mild and self-limiting

Long-Term or Rare Side Effects:

Alterations in glucose homeostasis: In susceptible individuals, changes in blood glucose regulation may occur; monitoring is advised for those with pre-existing glycemic issues

Unknown long-term effects: As a relatively recently discovered peptide, comprehensive long-term safety data in humans is limited

Disclaimer:

This information is for general knowledge and educational purposes only and does not constitute medical advice. Always consult with a qualified medical professional regarding any cosmetic or medical procedure.